Beijing Yuanxin Technology Co, which runs the pharmaceutical e-commerce platform Miaoshou Doctor in China, announced on Tuesday the completion of a Series F round at over 1.5 billion yuan ($232.1 million) from investors including Sequoia Capital China.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
